SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-017313
Filing Date
2023-11-02
Accepted
2023-11-02 07:05:13
Documents
14
Period of Report
2023-11-02
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20231102x8k.htm   iXBRL 8-K 41847
2 EX-99.1 tmb-20231102xex99d1.htm EX-99.1 15548
3 GRAPHIC tmb-20231102xex99d1001.jpg GRAPHIC 10630
  Complete submission text file 0001558370-23-017313.txt   197167

Data Files

Seq Description Document Type Size
4 EX-101.SCH tmb-20231102.xsd EX-101.SCH 3115
5 EX-101.LAB tmb-20231102_lab.xml EX-101.LAB 15921
6 EX-101.PRE tmb-20231102_pre.xml EX-101.PRE 10047
8 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20231102x8k_htm.xml XML 4848
Mailing Address 44 MILTON AVENUE ALPHARETTA GA 30009
Business Address 44 MILTON AVENUE ALPHARETTA GA 30009 8666208655
Virios Therapeutics, Inc. (Filer) CIK: 0001818844 (see all company filings)

IRS No.: 854314201 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39811 | Film No.: 231370020
SIC: 2834 Pharmaceutical Preparations